Newer treatments for hepatitis C, called direct-acting antiviral (DAA) regimens, are the standard of care for chronic hep C in the United States. DAAs help stop the virus from multiplying and spreading to other cells.
Years ago, hep C treatments took a long time and required injections. Today’s treatments are all oral and can be completed in as few as 8–24 weeks. Additionally, many of today's treatments have high cure rates of 95% or higher. A patient is considered cured if the hepatitis C virus is not detectable in their blood months after treatment has ended.
Evolution of hep C treatment
Older Hep C Treatment
Current Hep C Treatment
Direct-acting antivirals (DAAs)
DURATION† OF THERAPY
†Treatment duration depends on several factors, such as genotype.
Current therapies have high cure rates of 95% or greater according to clinical studies
*Being cured means the hepatitis C virus is not detectable in your blood months after treatment has ended.
Fewer side effects vs. older interferon-based therapies
Follow these simple steps to take action:
Your healthcare professional will look at your health history and decide if treatment is right for you. The treatment you receive and the length of treatment may depend on: